TOUJEO Max 300 U/mL

TOUJEO Max 300 U/mL is a long-acting insulin glargine injection designed for subcutaneous use. This solution is formulated to provide consistent blood sugar control in diabetic patients, offering a convenient 3 mL syringe option.

TOUJEO Max 300 U/mL is primarily used for the management of diabetes mellitus in adults. This insulin glargine injection helps regulate blood sugar levels over an extended period, supporting daily glucose control. Patients often inquire about what insulin glargine is used for, and it is commonly prescribed for those requiring long-term insulin therapy.

Common effects of TOUJEO Max 300 U/mL may include localized reactions at the injection site, such as redness or itching. Some users experience hypoglycemia, characterized by symptoms like sweating, dizziness, or confusion. These effects are generally mild and temporary, but consistent monitoring is advised.

TOUJEO Max 300 U/mL should be stored properly to maintain its efficacy. It is essential to follow the prescribed dosage and administration guidelines provided by a healthcare professional. Always check the solution for particles or discoloration before use, and avoid sharing syringes to prevent infection.

TOUJEO Max 300 U/mL may interact with other medications, including oral hypoglycemic agents and certain antihypertensive drugs. Alcohol consumption can also affect blood sugar levels, so moderation is advised. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.